TY - JOUR
T1 - Persistence of the circadian variation and altered response to hepatectomy of hepatic ornithine decarboxylase activity with malignant tumor burden
AU - Poston, Graeme J.
AU - Saydjari, Rami
AU - Lawrence, John P.
AU - Trudel, Judith L.
AU - Rubin, Norma H.
AU - Townsend, Courtney M.
AU - Thompson, James C.
N1 - Funding Information:
* Visiting Scientist from the Department of Surgery, Royal Postgraduate Medical School, University of London, London. U.K. Supported by the Wellcome Foundation, The Ethicon Foundation, and The British Digestive Foundation. t Visiting Scientist from the Department of Surgery, McGill University, and the Montreal General Hospital, Montreal, Canada. Fellow of the Medical Research Council of Canada (MRC).
Funding Information:
The authors are grateful to Prof. W. J. Rietveld. Department of Physiology, University of Leiden. The Netherlands, for performing the cosinar analysis. This work was supported by grants from the National Institutes of Health (5R37 DK 15241-19, POI DK 35608) and the American Cancer Society (PDT-220).
PY - 1993
Y1 - 1993
N2 - We measured the effect of MC-26 mouse colon cancers (of different sizes) on the circadian rhythm of hepatic ornithine decarboxylase (ODC) activity and hepatic ODC activity during the 24 hr after 60% hepatectomy. Tumor-free control mice showed a normal circadian rhythm of ODC activity with the highest levels at 1100 hr and the lowest levels at 2300 hr. The amplitude of the rhythm was diminished significantly in mice with a large tumor burden (3% of their body weight), and hepatic ODC activity was significantly less than in the tumor-free mice at every point during the 24 hr of the study. In mice with (early) tumors (0.3% of body weight), basal activity of ODC was normal and there was no reactive increase in activity following hepatectomy. In contrast, mice with (late) (3% of body weight) tumors had significantly lower basal ODC activities and the increase in ODC activity following hepatectomy was prolonged and exaggerated. We concluded that tumor burden is associated with abnormal ODC activity and that these differences are exaggerated after hepatectomy. Furthermore, although average ODC concentrations in tumor-bearing mice fell precipitously, the circadian rhythm in hepatic ODC persisted. This finding indicates early recognition by the host of tumor presence, which has a profound negative regulatory effect on hepatic ODC. Apparently, this effect does not impinge on circadian control mechanisms, indicating that these signals act independently.
AB - We measured the effect of MC-26 mouse colon cancers (of different sizes) on the circadian rhythm of hepatic ornithine decarboxylase (ODC) activity and hepatic ODC activity during the 24 hr after 60% hepatectomy. Tumor-free control mice showed a normal circadian rhythm of ODC activity with the highest levels at 1100 hr and the lowest levels at 2300 hr. The amplitude of the rhythm was diminished significantly in mice with a large tumor burden (3% of their body weight), and hepatic ODC activity was significantly less than in the tumor-free mice at every point during the 24 hr of the study. In mice with (early) tumors (0.3% of body weight), basal activity of ODC was normal and there was no reactive increase in activity following hepatectomy. In contrast, mice with (late) (3% of body weight) tumors had significantly lower basal ODC activities and the increase in ODC activity following hepatectomy was prolonged and exaggerated. We concluded that tumor burden is associated with abnormal ODC activity and that these differences are exaggerated after hepatectomy. Furthermore, although average ODC concentrations in tumor-bearing mice fell precipitously, the circadian rhythm in hepatic ODC persisted. This finding indicates early recognition by the host of tumor presence, which has a profound negative regulatory effect on hepatic ODC. Apparently, this effect does not impinge on circadian control mechanisms, indicating that these signals act independently.
UR - http://www.scopus.com/inward/record.url?scp=0027272908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027272908&partnerID=8YFLogxK
U2 - 10.3109/07357909309018872
DO - 10.3109/07357909309018872
M3 - Article
C2 - 8324645
AN - SCOPUS:0027272908
SN - 0735-7907
VL - 11
SP - 400
EP - 407
JO - Cancer Investigation
JF - Cancer Investigation
IS - 4
ER -